Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI)

The optimal first-line treatment for symptomatic patients with advanced stage follicular lymphoma remains unclear. Fludarabine-based combination regimens have been extensively used in relapsed disease and merit consideration as first-line therapy. We here report the results of a phase II study of FA...

Descripción completa

Detalles Bibliográficos
Autores principales: Yung, L, Cunningham, D, Hancock, B, Smith, P, Maclennan, K, Linch, D, McMillan, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364798/
https://www.ncbi.nlm.nih.gov/pubmed/15280929
http://dx.doi.org/10.1038/sj.bjc.6602031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364798/
https://www.ncbi.nlm.nih.gov/pubmed/15280929
http://dx.doi.org/10.1038/sj.bjc.6602031

Ejemplares similares